Abstract
The University of Central Florida invention is a novel 3D-printable, biodegradable and osteogenic composite scaffold that may be used as an implantable scaffold for bone repair. The material comprises poly(lactic acid) (PLA)-10 wt%, ß-tricalcium phosphate (TCP)-10 wt%, and CeO2 nanoparticles (CeNPs). It is fabricated by extrusion in the form of a filament and is subsequently used to prepare 3D constructs by additive manufacturing. The scaffolds act as temporary reparative material for bone regeneration and degrades into the body, producing non-toxic species as the tissue is completely regenerated. One example use of the 3D-printed PLA-TCP-CeNPs composite scaffold is as an alternative synthetic implant for bone repair to accelerate the regenerative process and avoid additional surgeries.
Partnering Opportunity: The research team is seeking partners for licensing, research collaboration, or both.
Stage of Development: Prototype available.
Benefit
Biodegradable, non-toxic, biocompatible materialEasily fabricated and stored for on-demand personalized medical applicationsAllows a cheaper and faster way to create implantable medical devicesMarket Application
Medical device manufacturers
Brochure
